[HTML][HTML] Laboratory biomarkers for diagnosis and prognosis in COVID-19
D Battaglini, M Lopes-Pacheco… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …
clinical manifestations, with progression to multiorgan failure in the most severe cases …
Long-term cardiovascular outcomes of COVID-19
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well
described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been …
described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been …
Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines
DK Shay, TT Shimabukuro, F DeStefano - JAMA cardiology, 2021 - jamanetwork.com
Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
Long COVID: a review and proposed visualization of the complexity of long COVID
R Perumal, L Shunmugam, K Naidoo… - Frontiers in …, 2023 - frontiersin.org
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
COVID-19 and the vasculature: current aspects and long-term consequences
B Martínez-Salazar, M Holwerda, C Stüdle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Rationale About 50% of hospitalized coronavirus disease 2019 (COVID-19) patients with
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …
Beneficial properties of bromelain
P Hikisz, J Bernasinska-Slomczewska - Nutrients, 2021 - mdpi.com
Bromelain is a major sulfhydryl proteolytic enzyme found in pineapple plants, having
multiple activities in many areas of medicine. Due to its low toxicity, high efficiency, high …
multiple activities in many areas of medicine. Due to its low toxicity, high efficiency, high …
The pathophysiology of long COVID throughout the renin-angiotensin system
S Khazaal, J Harb, M Rima, C Annweiler, Y Wu, Z Cao… - Molecules, 2022 - mdpi.com
COVID-19 has expanded across the world since its discovery in Wuhan (China) and has
had a significant impact on people's lives and health. Long COVID is a term coined by the …
had a significant impact on people's lives and health. Long COVID is a term coined by the …
Long‐term side effects and lingering symptoms post COVID‐19 recovery
Since the Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), our understanding regarding the …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), our understanding regarding the …